US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voya Infrastructure Industrials and Materials Fund

10.61

+0.09100.87%

Post-market: 10.610.00000.00%16:31 EDT

Volume:67.63K

Turnover:713.71K

Market Cap:204.55M

PE:- -

High:10.61

Open:10.54

Low:10.41

Close:10.52

Loading ...

Overview Company News Filings

Press Release: Spinal Stabilization Technologies(TM) Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc(TM) Nucleus Replacement Device

enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25

ACCESS Newswire

MPLAB® XC Unified Compiler Licenses Deliver Streamlined Software Management

Voya Equity Closed End Funds Declare Distributions

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Monthly Distribution

Datavault AI’s VerifyU™ Expands Presence in Academic Web 3.0 Credential Verification

WiSA Technologies is Now Datavault AI Inc.

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Datavault AI Signs Interoperability License Agreement with Dolby

Datavault AI Revolutionizes Luxury Fashion at the New York Fashion Week with DVHolo™ and ADIO® Technologies

NFL Alumni Health Selects Datavault AI to Amplify DEA’s "One Pill Can Kill" Campaign Using ADIO Tones at Super Bowl LIX

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day

Datavault Furthers VerifyU Commercialization Strategy in 3 Year Deal to Mint Immutable Tokens for NFL Alumni Past, Present and Future

Corrections - Philux Global Group to Expedite Closings of Largest Financing Transactions

WiSA Technologies and Data Vault Holdings’ Revolutionary Technologies Showcased at CES 2025 and Highlighted by Forbes

Philux Global Group to Expedite Closings of Largest Financing Transactions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IDE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","market":"US","secType":"STK","nameCN":"Voya Infrastructure Industrials and Materials Fund","latestPrice":10.61,"timestamp":1743624000000,"preClose":10.519,"halted":0,"volume":67629,"hourTrading":{"tag":"盘后","latestPrice":10.61,"preClose":10.61,"latestTime":"16:31 EDT","volume":35,"amount":369.7,"timestamp":1743625860533},"delay":0,"floatShares":0,"shares":19279000,"eps":0,"marketStatus":"Not Yet Opened","change":0.091,"latestTime":"04-02 16:00:00 EDT","open":10.54,"high":10.61,"low":10.41,"amount":713710.4362,"amplitude":0.019013,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":10.519,"aum":0,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":10.61,"preClose":10.61,"latestTime":"16:31 EDT","volume":35,"amount":369.7,"timestamp":1743625860533},"volumeRatio":1.281503},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.281503,"shares":19279000,"dividePrice":1.2,"high":10.61,"amplitude":0.019013,"preClose":10.519,"low":10.41,"week52Low":9.8416,"pbRate":"--","week52High":11.766,"institutionHeld":0,"latestPrice":10.61,"eps":0,"divideRate":0.113101,"volume":67629,"delay":0,"ttmEps":0,"open":10.54,"prevYearClose":10.15,"prevWeekClose":10.55,"prevMonthClose":10.58,"prevQuarterClose":10.58,"fiveDayClose":10.62,"twentyDayClose":10.49,"sixtyDayClose":10.23},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516654979","title":"Press Release: Spinal Stabilization Technologies(TM) Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc(TM) Nucleus Replacement Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516654979?lang=en_us&edition=fundamental","pubTime":"2025-03-04 02:17","pubTimestamp":1741025820,"startTime":"0","endTime":"0","summary":"Spinal Stabilization Technologies Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc Nucleus Replacement Device. Dr. Pierce Nunley completes the first U.S. PerQdisc Surgery Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors. Spine Surgeon Frank Phillips, MD Joins Board of Spinal Stabilization Technologies. SST is also pleased to announce the appointment of Dr. Frank Phillips to its Board of Directors. Dr. Phillips is one of the world's leading spine surgeons and has been the president of global spine societies. He has pioneered minimally invasive procedures, has over 200 spine-related publications and trained numerous spine surgeons. He holds patents in the spine space, has founded spine companies and served on the board of directors of public and private companies. \"His expertise and leadership in the field of spinal surgery will be instrumental in guiding SST's strategic direction and clinical adoption,\" commented Mark Novotny, CEO of SST.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4588","BK4077","TM","BK4585","BK4161","DDD","BK4170","BK4551","BK4546","IDE","SST","BK4604","03160","BK4099"],"gpt_icon":0},{"id":"2514324902","title":"enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324902","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324902?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"Cash Burn of $5.2 million in Q4 remains in line with projected $4-5 million quarterly range. Cash and investments on hand are sufficient to fund operations beyond the anticipated regulatory approval of VenoValve and the initiation of the enVVe pivotal trial. PMA application for the VenoValve submitted, with FDA decision expected in the second half of 2025. On track for enVVe IDE application submission by mid-2025, pending GLP study results. IRVINE, CA / ACCESS Newswire / February 28, 2025 / enVVeno Medical Corporation  , a company setting new standards of care for the treatment of venous disease, today provided a corporate update and reported financial results for the fourth quarter and year-end of 2024.The Company reported net losses of $21.8 million and $23.5 million for the years ended December 31, 2024 and 2023, respectively, representing a decrease in net loss of $1.7 million or 7%, resulting from a decrease in operating expenses of $1.5 million, and an increase in other income of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/envveno-medical-reports-fourth-quarter-130000940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVI","PRGS","NVNO","BK4138","BK4097","IDE","LU2065732104.USD","BK4082"],"gpt_icon":0},{"id":"2513043728","title":"MPLAB® XC Unified Compiler Licenses Deliver Streamlined Software Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2513043728","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513043728?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:07","pubTimestamp":1740398820,"startTime":"0","endTime":"0","summary":"Unified solution allows Microchip Technology to provide flexible and cost-effective licensing options for its line of compilers. CHANDLER, Ariz., Feb. 24, 2025  -- Offering an efficient way to manage multiple licenses, Microchip Technology  has launched MPLAB XC Unified Compiler Licensesfor its MPLAB XC8, XC16, XC-DSC and XC32 C compilers. This unified approach addresses the financial strain and administrative burden of purchasing and managing separate software access models for each compiler. Microchip’s solution consolidates the necessary licenses to reduce overhead and provide greater flexibility, scalability and ease of use.The unified system is designed to accommodate evolving development needs, offering multiple tiers to suit growing teams. The Workstation License can be installed and executed on up to three host machines for use by a single engineer. The Network Server License allows installation on a server, accessible by any machine on the network, one at a time. The Subscript","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mplab-xc-unified-compiler-licenses-120700904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IDE","BK4529","BK4141","BK4588","LU1983260115.SGD","LU0342679015.USD","BK4604","LU2357305700.SGD","BK4605","LU2087625088.SGD","LU1720051017.SGD","MCHP","LU0353189680.USD","BK4512","LU0348723411.USD","LU1548497426.USD","IPE","BK4585","XC","LU0353189763.USD","LU1720051108.HKD"],"gpt_icon":0},{"id":"2512903031","title":"Voya Equity Closed End Funds Declare Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2512903031","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512903031?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:30","pubTimestamp":1739914200,"startTime":"0","endTime":"0","summary":"With respect to each Fund, the distribution will be paid on March 17, 2025, to shareholders of record on March 3, 2025. The ex-dividend date is March 3, 2025. The distribution per share for each Fund is as follows:. Voya Global Equity Dividend and Premium Opportunity Fund . Voya Asia Pacific High Dividend Equity Income Fund . The following table sets forth an estimate of the sources of each Fund’s January distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.Set forth in the tables below is information relating to each Fund’s performance based on its net asset value  for certain periods.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/voya-equity-closed-end-funds-213000770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211331839.USD","EQR","BK4215","LU1878469433.USD","IDE","IGA","IHD","LU0061475181.USD","NAV","IGD","BK4585","VOYA","BK4184","BK4588","IAE"],"gpt_icon":0},{"id":"2512192007","title":"Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Monthly Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2512192007","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512192007?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:15","pubTimestamp":1739913300,"startTime":"0","endTime":"0","summary":"The amounts and sources of distributions reported in this notice are estimates, are not being provided for tax reporting purposes and the distribution may later be determined to be from other sources including realized short-term gains, long-term gains, to the extent permitted by law, and return of capital. The actual amounts and sources for tax reporting purposes will depend upon the Funds’ investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.Monthly Distribution: Payable February 18, 2025Distribution Amount per Common Share : $0.085Distribution Amount per Common Share : $0.100. The following table sets forth an estimate of the sources of the Fund’s February distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/voya-global-advantage-premium-opportunity-211500687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAV","IDE","VOYA","BK4544","BK4585","IGA","ARKG","BK4588"],"gpt_icon":0},{"id":"2512168875","title":"Datavault AI’s VerifyU™ Expands Presence in Academic Web 3.0 Credential Verification","url":"https://stock-news.laohu8.com/highlight/detail?id=2512168875","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512168875?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:50","pubTimestamp":1739886600,"startTime":"0","endTime":"0","summary":"Reinforcing sales efforts for identity verification in higher education,targeting a $177 billion global market with artificial intelligence enabled solutions. NEW YORK, February 18, 2025----Datavault AI Inc. , leading the way in AI data experience, valuation, and monetization, expanded its presence in academic credential verification by hiring Michael Nisbet as Vice President of Sales, Education. With over 20 years of experience working with organizations like Harvard, Stanford and Google, Nisbet will drive efforts to deliver Datavault AI’s VerifyU, the technology stack that provides critical tools to academic institutions worldwide.Nathaniel Bradley, CEO of Datavault AI stated, \"VerifyU empowers institutions to reduce administrative costs through the use of AI solutions, ensuring compliance and maintaining trust through secure AI technology that can serve graduates and institutions alike. With his expertise and leadership in institutional partnerships, systems integration, and market ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datavault-ai-verifyu-expands-presence-135000875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2756315664.SGD","LU1720051108.HKD","LU1868837300.USD","LU2092937148.SGD","LU1496350171.SGD","BK4579","IE0034235303.USD","BK4566","IE0034235188.USD","IDE","LU0256863811.USD","LU0353189680.USD","LU2602419157.SGD","ML","LU2505996509.AUD","LU1935042488.USD","LU2491049909.HKD","LU1791710400.SGD","LU0426412945.USD","LU1221951129.SGD","BK4533","SGXZ99366536.SGD","LU2077746001.SGD","LU0683600562.USD","LU1935043023.USD","LU1196500208.SGD","BK4538","LU2236285917.USD","LU1032955483.USD","LU2271345857.HKD","SG9999015945.SGD","DVLT","LU1988902786.USD","LU1145028129.USD","LU0345774631.USD","BK4527","BK4574","LU0251142724.SGD","LU1633808545.USD","LU2420271590.USD","GOOGL","LU0316494557.USD","LU0689472784.USD","IE00BQXX3C00.GBP","IE00BSNM7G36.USD","LU2242649171.HKD","BK4602","LU0640476718.USD","BK4561"],"gpt_icon":1},{"id":"2511204055","title":"WiSA Technologies is Now Datavault AI Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2511204055","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511204055?lang=en_us&edition=fundamental","pubTime":"2025-02-14 00:50","pubTimestamp":1739465400,"startTime":"0","endTime":"0","summary":"Completes corporate rebranding under Data Science and Acoustic Science divisionsAnnounces new Nasdaq ticker symbol DVLT, effective on February 14, 2025. Nathaniel T. Bradley, CEO of Datavault AI, said, \"Completing our rebranding as Datavault AI, we’ve aligned the company with our core focus and broad reach into multiple, rapidly growing markets. We have integrated our assets, organized under our Data Science and Acoustic Science divisions. Now, we are well-positioned to realize partnering opportunities and grow the business across multiple vertical markets in 2025 and beyond.\". Datavault AI is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two primary solutions:. This press release of Datavault AI contains forward-looking statements within the meanin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wisa-technologies-now-datavault-ai-165000966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4166","BK4141","IDE","ML","WISA"],"gpt_icon":0},{"id":"2511547699","title":"Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2511547699","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511547699?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:01","pubTimestamp":1739451660,"startTime":"0","endTime":"0","summary":"Aethlon Medical invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.SAN DIEGO, Feb. 13, 2025 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 19, 2025.This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with Aethlon Medical's Chief Executive Officer, Mr. James Frakes, in real time.Mr. Frakes will perform a presentation and may subsequently open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and Mr. Frakes will do his best to get through as many of them as possible.Aethlon Medical, Inc. will be presenting ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aethlon-medical-present-emerging-growth-130100479.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aethlon-medical-present-emerging-growth-130100479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IDE","AEMD","BK4583","BK4568","BK4082"],"gpt_icon":0},{"id":"2511333665","title":"Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2511333665","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511333665?lang=en_us&edition=fundamental","pubTime":"2025-02-13 05:15","pubTimestamp":1739394900,"startTime":"0","endTime":"0","summary":"Key Milestone Achieved: First Patient treated inHemopurifier Safety, Feasibility, and Dose Finding Study for Solid Tumors Not Responding to Anti-PD-1 Antibodies. Patient Enrollment Open at Two Australian for Hemopurifier Cancer Trial. SAN DIEGO, Feb. 12, 2025 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2024 and provided an update on recent developments.During the third quarter, and subsequently, the company made significant progress in its oncology trial efforts in Australia while executing cost-cutting measures to enhance operational efficiency. Management is pleased to highlight the following key developments:. The company is pleased to announce that the Human Research Ethics Committees  and Research Governance Offices  have approved this amendment at all thre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aethlon-medical-announces-financial-results-211500546.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aethlon-medical-announces-financial-results-211500546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","AEMD","BK4082","IDE","BK4568"],"gpt_icon":0},{"id":"2510377553","title":"Datavault AI Signs Interoperability License Agreement with Dolby","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377553","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510377553?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:47","pubTimestamp":1739368020,"startTime":"0","endTime":"0","summary":"New Interoperability Agreement Accelerates Wireless Audio Integration for Android and Linux A/V Platforms. BEAVERTON, Ore., February 12, 2025----WiSA Technologies, Inc. , soon to be doing business as Datavault AI, today announced a new interoperability license agreement with Dolby. This agreement allows Datavault AI to collaborate directly with system-on-chip  providers to integrate its patented WiSA E Express multichannel wireless audio software into Android and future Linux-based streaming A/V platforms.\"WiSA E Express was created to simplify wireless audio and address the long-standing issue of poor sound quality in TVs and STBs,\" said Tony Parker, VP of Business Development and Strategy at WiSA Technologies. \"We’ve solved major industry challenges, including ensuring robust performance over existing Wi-Fi connections, while introducing a lower-cost activation model that meets consumer demand.\". The market expansion is further fueled by the rise of smart TVs, home theater systems, a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datavault-ai-signs-interoperability-license-134700476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ML","BK4166","WISA","BK4141","IDE"],"gpt_icon":0},{"id":"2510857936","title":"Datavault AI Revolutionizes Luxury Fashion at the New York Fashion Week with DVHolo™ and ADIO® Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2510857936","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510857936?lang=en_us&edition=fundamental","pubTime":"2025-02-10 21:33","pubTimestamp":1739194380,"startTime":"0","endTime":"0","summary":"ADIO-Powered Holograms Showcase Digital Couture at SHAO New York’s Fashion Week 1025 Collection. NEW YORK, February 10, 2025----WiSA Technologies, Inc. , soon to be doing business as Datavault AI, is introducing a fusion of its DVHolo holographic display and ADIO technologies at New York Fashion Week  through its collaboration with Shao Yang, founder and designer of SHAO New York.Fashion houses are exploring new ways to captivate audiences beyond the traditional runway. The holographic display market is projected to exceed $23 billion by 20321, driven by rising demand for experiential retail and next-generation fashion showcases, while AI-driven personalization in luxury fashion is expected to reach $5.6 billion by 20342, reflecting the shift toward data-driven, immersive brand storytelling in high-end retail. Datavault AI’s DVHolo and ADIO technologies provide a competitive advantage in this emerging digital transformation, enabling fashion houses to seamlessly integrate physical cout","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datavault-ai-revolutionizes-luxury-fashion-133300778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ML","BK4141","WISA","BK4166","IDE"],"gpt_icon":0},{"id":"2509240285","title":"NFL Alumni Health Selects Datavault AI to Amplify DEA’s \"One Pill Can Kill\" Campaign Using ADIO Tones at Super Bowl LIX","url":"https://stock-news.laohu8.com/highlight/detail?id=2509240285","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509240285?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:11","pubTimestamp":1738761060,"startTime":"0","endTime":"0","summary":"- ADIO Tones to Deliver Geo-Targeted PSAs and Promote Community Engagement -. - NFL Alumni Association Repeat Usage of ADIO Tones Validates Datavault AI for PSAs -. \"Leveraging the substantial public attention to the Super Bowl, NFL Alumni Health teamed up with the DEA to augment the ‘One Pill Can Kill’ messaging campaign to thwart the fentanyl epidemic,\" stated Billy Davis, a two-time Super Bowl champion with the Dallas Cowboys and Baltimore Ravens and a co-director to the NFL Alumni Health, which is sponsoring the ‘Huddle For Health’ Symposium. For more information on the campaign, visit dea.gov/onepill.Billy Davis continued, \"As a nonprofit dedicated to promoting the health and well-being of NFL alumni and their communities, we recognized the importance of teaming up with the DEA and Datavault AI to deliver this critical, life-saving message. The technology enhances audience engagement by ensuring PSAs reach people in real time, seamlessly integrating with existing event sound syste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nfl-alumni-health-selects-datavault-131100870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4141","BK4194","BK4223","DEA","WISA","IDE"],"gpt_icon":0},{"id":"2509285999","title":"Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509285999","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509285999?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:01","pubTimestamp":1738760460,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb. 5, 2025 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2024, at 4:15 p.m. ET on Wednesday, February 12, 2025.Interested parties without internet access or unable to pre-register may dial in by calling:. PARTICIPANT DIAL IN : 1-844-836-8741PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442. All callers should ask for the Aethlon Medical, Inc. conference call.A replay of the call will be available approximately one hour after the end of the call through March 12, 2025. The replay can be accessed via Aethlon Medical's website or by dialing 1-877-344-7529  or 1-412-317-0088  or Canada toll free at 1-855-669-9658. The replay conference ID number is 7828175.Forward Looking StatementsThis press release contains forward-looking statements within the meaning of Section 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aethlon-medical-release-fiscal-third-130100486.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aethlon-medical-release-fiscal-third-130100486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","BK4218","HST","BK4181","BK4082","IDE","BK4585","BK4568","BK4588","AEMD"],"gpt_icon":0},{"id":"2508143549","title":"Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2508143549","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508143549?lang=en_us&edition=fundamental","pubTime":"2025-02-03 21:30","pubTimestamp":1738589400,"startTime":"0","endTime":"0","summary":"JERUSALEM, Feb.  03, 2025  (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (\"Alpha Tau\", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/03/3019526/0/en/Alpha-Tau-Announces-FDA-Approval-of-IDE-Supplement-to-Expand-Pilot-Trial-of-Alpha-DaRT-to-Thirty-Patients-with-Pancreatic-Cancer-in-Two-Cohorts-with-Locally-Advanced-or-Metastatic-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","IE00B66KJ199.SGD","BK4082","IE00B7SZL793.SGD","IDE","IE00B19Z4B17.USD","AEIS","BK4157","IE0031619046.USD"],"gpt_icon":0},{"id":"2507963633","title":"Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2507963633","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507963633?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:01","pubTimestamp":1738155660,"startTime":"0","endTime":"0","summary":"First Patient enrolled and treated at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital. SAN DIEGO, Jan. 29, 2025 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced a significant milestone: the treatment of the first patient with the Hemopurifier in its Australian safety, feasibility and dose-finding clinical trial of the Hemopurifier. This trial is designed for patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda  or Opdivo  . The patient was enrolled on October 29, 2024, by Prof. Michael Brown and his staff at the Cancer Clinical Trials Unit, CALHN, Royal Adelaide Hospital in Australia, and treated with the Hemopurifer on January 29, 2025, by Prof. Toby Coates and the dialysis staff.The primary endpoint of the approximately 18-patient, safety, feasibility, and dose-finding trial i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aethlon-medical-treats-first-patient-130100851.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aethlon-medical-treats-first-patient-130100851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IDE","BK4082","AEMD","BK4583","BK4568"],"gpt_icon":0},{"id":"2506744377","title":"Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2506744377","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506744377?lang=en_us&edition=fundamental","pubTime":"2025-01-27 22:00","pubTimestamp":1737986400,"startTime":"0","endTime":"0","summary":"- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT -. - Ad-hoc analyses of pancreatic cancer population subgroups suggest meaningful improvement in median overall survival  for patients treated with Alpha DaRT after prior therapy, compared to previously published studies of alternative monotherapies, across all analyzed subgroups –。- Approval received from France’s Ministry of Health to commence French multicenter clinical trial of Alpha DaRT alongside capecitabine for patients with locally advanced pancreatic cancer -. Across three ongoing feasibility and safety trials, two in Canada and one in Israel, 41 patients with pancreatic cancer had been treated with Alpha DaRT in Canada  and Israel , including the first five patients for whom interim data was already released in late 2023. A 100% success rate was achieved in delivering the Alpha DaRT sources , and strong safety results were o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-tau-announces-cornerstone-interim-140000086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","CPS","OS","BK4124","DRTSW","DRTS","IDE","BK4097"],"gpt_icon":0},{"id":"2505659747","title":"Datavault Furthers VerifyU Commercialization Strategy in 3 Year Deal to Mint Immutable Tokens for NFL Alumni Past, Present and Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2505659747","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505659747?lang=en_us&edition=fundamental","pubTime":"2025-01-22 21:17","pubTimestamp":1737551820,"startTime":"0","endTime":"0","summary":"VerifyU credentialing with patented ADIO & WiSA technologies to connect NFL alumni to benefits and statistical credentials, fans, venues and events with acoustic mobile quick response. \"We are focused on the immediate commercialization of VerifyU, Data Vault, ADIO and our WiSA families of technologies that will be introduced through NFLA, and we are honored to initiate our work with this agreement,\" said Nathaniel Bradley, CEO of WiSA Technologies. \"This agreement leverages VerifyU, our patented blend of Data Vault and ADIO, as an advertising platform that we will monetize as a percentage of sales in a split with the NFLA.\". \"This groundbreaking partnership with Datavault AI is a pivotal advancement in our efforts to empower NFL Alumni by adding a crucial building block to our Name, Image, and Likeness  vertical,\" stated Brad Edwards, CEO of the NFL Alumni Association. \"This collaboration not only enhances access to benefits but also creates new revenue streams, ensuring our members ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datavault-furthers-verifyu-commercialization-strategy-131700056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4141","IDE","WISA"],"gpt_icon":0},{"id":"2505345273","title":"Corrections - Philux Global Group to Expedite Closings of Largest Financing Transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2505345273","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505345273?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:30","pubTimestamp":1737466200,"startTime":"0","endTime":"0","summary":"-The proposed Asian Diamond Exchange  intends to apply for membership in the World Federation of Diamond Bourses  in the near future.-Philux Global Energy to initially focus on fossil fuel power plants, EV charging stations and hybrid vehicle engines.Though we have experienced long delays with the smaller financing packages due to various reasons which are currently being addressed for immediate resolutions, the Company is putting forth our best efforts with strong steps to close these two largest financing transactions in the coming weeks.The Company intends to immediately use the funds from these largest financing agreements primarily for investment in select projects within key sectors and special investment opportunities in Vietnam and USA, especially and most urgently the Asian Diamond Exchange  and the International Financial Center  projects in Vietnam and the geomagnetic energy technology by Philux Global Energy, Inc. .Regarding the geomagnetic energy technology, Philux Global ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corrections-philux-global-group-expedite-133000959.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","PHIG","CAGR","BK4585","IDE","PHIGW","BK4159","BK4597","BK4588","ESS"],"gpt_icon":0},{"id":"2505797220","title":"WiSA Technologies and Data Vault Holdings’ Revolutionary Technologies Showcased at CES 2025 and Highlighted by Forbes","url":"https://stock-news.laohu8.com/highlight/detail?id=2505797220","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505797220?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:17","pubTimestamp":1737465420,"startTime":"0","endTime":"0","summary":"Digital Twins Steal the Show; Inaudible Tone Technology, Holographic Solutions, Immersive Audio, and Web 3.0 Technologies Take Center Stage. LAS VEGAS, January 21, 2025----WiSA Technologies, Inc.  today announced CES 2025 was highly successful with WiSA and Datavault brands demonstrating groundbreaking Web 3.0 technologies. Recognition from Forbes in its \"Highlights from CES 2025\"1 underscores the innovations’ relevance and industry impact.Industry Recognition: Forbes noted the patented innovations are significant and the tools are designed to simplify how people learn, share, and experience content digitally.Wide Reach: The WiSA/ADIO booth engaged approximately 35 companies, ranging from top-level brands to innovators, fostering partnerships across technology and consumer markets.\"The response at CES validated our strategy to invest in breakthrough technologies that enhance how businesses monetize and engage with their customers,\" said Nate Bradley, CEO of WiSA Technologies. \"The ment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wisa-technologies-data-vault-holdings-131700999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WISA","BK4141","IDE"],"gpt_icon":0},{"id":"2504116179","title":"Philux Global Group to Expedite Closings of Largest Financing Transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2504116179","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504116179?lang=en_us&edition=fundamental","pubTime":"2025-01-18 04:10","pubTimestamp":1737144600,"startTime":"0","endTime":"0","summary":"Though we have experienced long delays with the smaller financing packages due to various reasons which are currently being addressed for immediate resolutions, the Company is putting forth our best efforts with strong steps to close these two largest financing transactions in the coming weeks.The Company intends to immediately use the funds from these largest financing agreements primarily for investment in select projects within key sectors and special investment opportunities in Vietnam and USA, especially and most urgently the Asian Diamond Exchange  and the International Financial Center  projects in Vietnam and the geomagnetic energy technology by Philux Global Energy, Inc. .The distinctive advantages of this “Multi-Impulse Energy System” include: 1) not depending on weather conditions, 2) does not require much land","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/philux-global-group-expedite-closings-201000124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4176","IDE","BK4179","BK4585","BK4215","PHIG","ESS","PHIGW","BK4588","BK4597"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":92}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDE\",params:#limit:5,,,undefined,":[{"date":"2025-04-01","symbol":"IDE","amount":0.1,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-15","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-15"},{"date":"2025-03-03","symbol":"IDE","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-17","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-17"},{"date":"2025-02-03","symbol":"IDE","amount":0.1,"announcedDate":"2025-01-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-03","defaultRemindTime":1738593000000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-18","payableDate":"2025-02-03","currency":"USD","dateTimestamp":1738558800000,"payDate":"2025-02-18"},{"date":"2024-12-30","symbol":"IDE","amount":0.1,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-15","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-15"},{"date":"2024-12-02","symbol":"IDE","amount":0.1,"announcedDate":"2024-11-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-02","defaultRemindTime":1733149800000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-16","payableDate":"2024-12-02","currency":"USD","dateTimestamp":1733115600000,"payDate":"2024-12-16"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDE\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-07-15","value":0.405,"currency":"USD"},{"executeDate":"2015-10-01","recordDate":"2015-10-05","paymentDate":"2015-10-15","value":0.365,"currency":"USD"},{"executeDate":"2015-12-29","recordDate":"2015-12-31","paymentDate":"2016-01-15","value":0.365,"currency":"USD"},{"executeDate":"2016-04-01","recordDate":"2016-04-05","paymentDate":"2016-04-15","value":0.365,"currency":"USD"},{"executeDate":"2016-07-01","recordDate":"2016-07-06","paymentDate":"2016-07-15","value":0.365,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDE\",market:\"US\",delay:false,,,undefined,":{}}}